Transparency in Research involving Animals: The Basel Declaration and new principles for reporting research in BJP manuscripts
Quantitative structure–activity relationship analysis of the pharmacology of para -substituted methcathinone analogues
Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach
9-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels
Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain
Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties
GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature
GPCR dimerization in brainstem nuclei contributes to the development of hypertension
The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
Divergent effects of the ‘biased’ 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task
Effects of the novel BK (KCa1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKβ subunits
Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics
Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5
LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma
In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin
The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy
The long-acting β2-adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner
A novel selective and orally bioavailable Nav1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability